Morgan Stanley Equal-Weight on MAKO Surgical

Morgan Stanley is out with a research report on MAKO Surgical MAKO and it has an Equal-Weight rating on shares. In a note to clients, Morgan Stanley writes, "In a healthcare environment characterized by weak utilization, MAKO delivered a solid quarter and increased the low end of procedure guidance. Inline system placements and accelerating utilization in a seasonally weak 3Q were encouraging considering reported pressures on elective uni-knee procedures. System pricing appears stable adjusting for both hip upgrades and isolated conversion of non-commercial units." Shares of MAKO closed at $33.34 yesterday/